Durvalumab in novel combinations for head and neck cancer
11 Sep 2017
Durvalumab in novel combinations for head and neck cancer
Treatment choices in thyroid cancer
Problems with survivorship care in Europe
Underprovision and inequality of specialised cancer care
Regorafenib versus lomustine for relapsed glioblastoma
Editor's Choice for August 2017
Editor's Choice for July 17
iManageCancer: Serious Games for Kids
The unmet needs of cancer survivors
Precision medicine: a nurses perspective
New drug advancements presented at ASCO
iManageCancer: Psycho-emotional and family resilience monitoring